JPM Thematics - Genetic Therapies I2 Fonds
97,20
EUR
+2,18
EUR
+2,29
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| uniQure NV | NL0010696654 | 3,90% |
| Ionis Pharmaceuticals Inc | US4622221004 | 3,40% |
| CRISPR Therapeutics AG | CH0334081137 | 3,40% |
| PTC Therapeutics Inc | US69366J2006 | 3,39% |
| Wuxi AppTec Co Ltd | CNE100003F19 | 3,09% |
| Novartis AG Registered Shares | CH0012005267 | 3,02% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,01% |
| Gilead Sciences Inc | US3755581036 | 2,82% |
| Astellas Pharma Inc | JP3942400007 | 2,81% |
| Krystal Biotech Inc | US5011471027 | 2,72% |
| Sonstige | 68,45% |